entity

H63D HFE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about H63D HFE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

6Connections
1Hypotheses
1Analyses
6Outgoing
0Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (6)

TargetRelationTypeStr
autophagic fluximpairsprocess0.70
alpha-synuclein expressionaltersprocess0.70
mitochondrial iron handlingaltersprocess0.70
IRP2-IREP axismodulatespathway0.70
labile iron poolaltersprocess0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
H63D HFE Genotype-Guided Iron Chelation Therapy for Subset-S 0.550 - Ferroptosis in ALS and motor neuron dise

Mentioning Analyses (1)

Scientific analyses that reference this entity

Why does iron chelation therapy worsen outcomes in H63D HFE variant carriers des

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.586

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The study shows deferiprone rescues wild-type cells but exacerbates toxicity in

closed · Rounds: 4 · Score: 0.95 · 2026-04-15

Related Research

Hypotheses and analyses mentioning H63D HFE in their description or question text

No additional research found